Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H23F3N2O4S |
Molecular Weight | 504.521 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=C(CCC2=NOC3=CC(OCC(O)=O)=C(C)C=C23)SC(=N1)C4=CC=C(C=C4)C(F)(F)F
InChI
InChIKey=WWKYLBGQYALEDL-UHFFFAOYSA-N
InChI=1S/C25H23F3N2O4S/c1-13(2)23-21(35-24(29-23)15-4-6-16(7-5-15)25(26,27)28)9-8-18-17-10-14(3)19(33-12-22(31)32)11-20(17)34-30-18/h4-7,10-11,13H,8-9,12H2,1-3H3,(H,31,32)
Molecular Formula | C25H23F3N2O4S |
Molecular Weight | 504.521 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Senju Pharmaceutical is developing fonadelpar (also known as SJP-0035), a peroxisome proliferator activated receptor delta agonist as an ophthalmic solution. Fonadelpar was studied in phase III clinical trial in the USA for the treatment of patients with dry eye disease. This study was successfully completed. In addition, fonadelpar was involved in phase II clinical trial in the USA for the treatment of patients with moderate to severe corneal epithelial disorders. Besides, Senju Pharmaceutical also plans a phase II trial for corneal disorders in Japan.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT03527212
Self-administration of 1 drop (approximately 40 µL) of 0.001% SJP-0035 (FONADELPAR) ophthalmic solution into each eye 4 times daily for 4 weeks
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:31:52 GMT 2023
by
admin
on
Sat Dec 16 08:31:52 GMT 2023
|
Record UNII |
FK5ZAD810Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
BC-86
Created by
admin on Sat Dec 16 08:31:52 GMT 2023 , Edited by admin on Sat Dec 16 08:31:52 GMT 2023
|
PRIMARY | |||
|
C170003
Created by
admin on Sat Dec 16 08:31:52 GMT 2023 , Edited by admin on Sat Dec 16 08:31:52 GMT 2023
|
PRIMARY | |||
|
CHEMBL3545186
Created by
admin on Sat Dec 16 08:31:52 GMT 2023 , Edited by admin on Sat Dec 16 08:31:52 GMT 2023
|
PRIMARY | |||
|
FK5ZAD810Z
Created by
admin on Sat Dec 16 08:31:52 GMT 2023 , Edited by admin on Sat Dec 16 08:31:52 GMT 2023
|
PRIMARY | |||
|
515138-06-4
Created by
admin on Sat Dec 16 08:31:52 GMT 2023 , Edited by admin on Sat Dec 16 08:31:52 GMT 2023
|
PRIMARY | |||
|
9827461
Created by
admin on Sat Dec 16 08:31:52 GMT 2023 , Edited by admin on Sat Dec 16 08:31:52 GMT 2023
|
PRIMARY | |||
|
300000034227
Created by
admin on Sat Dec 16 08:31:52 GMT 2023 , Edited by admin on Sat Dec 16 08:31:52 GMT 2023
|
PRIMARY | |||
|
10105
Created by
admin on Sat Dec 16 08:31:52 GMT 2023 , Edited by admin on Sat Dec 16 08:31:52 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |